86 related articles for article (PubMed ID: 25350923)
1. Hybrids of phenylsulfonylfuroxan and coumarin as potent antitumor agents.
Liu MM; Chen XY; Huang YQ; Feng P; Guo YL; Yang G; Chen Y
J Med Chem; 2014 Nov; 57(22):9343-56. PubMed ID: 25350923
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and anti-tumor evaluation of novel steroidal glycoconjugate with furoxan derivatives.
Li H; Wang K; Wan Q; Chen Y
Steroids; 2019 Jan; 141():81-95. PubMed ID: 30521816
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Antitumor Evaluation of Novel Hybrids of Phenylsulfonylfuroxan and Estradiol Derivatives.
Wan Q; Deng Y; Huang Y; Yu Z; Wang C; Wang K; Dong J; Chen Y
ChemistryOpen; 2020 Feb; 9(2):176-182. PubMed ID: 32025462
[TBL] [Abstract][Full Text] [Related]
4. A hybrid of coumarin and phenylsulfonylfuroxan induces caspase-dependent apoptosis and cytoprotective autophagy in lung adenocarcinoma cells.
Wang Q; Guo Y; Jiang S; Dong M; Kuerban K; Li J; Feng M; Chen Y; Ye L
Phytomedicine; 2018 Jan; 39():160-167. PubMed ID: 29433677
[TBL] [Abstract][Full Text] [Related]
5. Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity.
Ling Y; Ye X; Zhang Z; Zhang Y; Lai Y; Ji H; Peng S; Tian J
J Med Chem; 2011 May; 54(9):3251-9. PubMed ID: 21504204
[TBL] [Abstract][Full Text] [Related]
6. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells.
Wang CC; Chiang YM; Sung SC; Hsu YL; Chang JK; Kuo PL
Cancer Lett; 2008 Jan; 259(1):82-98. PubMed ID: 18023967
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor evaluation of novel hybrids of phenylsulfonylfuroxan and epiandrosterone/dehydroepiandrosterone derivatives.
Huang Y; Liu M; Meng L; Feng P; Guo Y; Ying M; Zhu X; Chen Y
Steroids; 2015 Sep; 101():7-14. PubMed ID: 26004429
[TBL] [Abstract][Full Text] [Related]
8. Novel hybrids of (phenylsulfonyl)furoxan and anilinopyrimidine as potent and selective epidermal growth factor receptor inhibitors for intervention of non-small-cell lung cancer.
Han C; Huang Z; Zheng C; Wan L; Zhang L; Peng S; Ding K; Ji H; Tian J; Zhang Y
J Med Chem; 2013 Jun; 56(11):4738-48. PubMed ID: 23668441
[TBL] [Abstract][Full Text] [Related]
9. Novel Hybrids of 3-Substituted Coumarin and Phenylsulfonylfuroxan as Potent Antitumor Agents with Collateral Sensitivity against MCF-7/ADR.
Yu Z; Li M; Wang K; Gu Y; Guo S; Wang W; Ma Y; Liu H; Chen Y
J Med Chem; 2022 Jul; 65(13):9328-9349. PubMed ID: 35737669
[TBL] [Abstract][Full Text] [Related]
10. Antitumor agents 292. Design, synthesis and pharmacological study of S- and O-substituted 7-mercapto- or hydroxy-coumarins and chromones as potent cytotoxic agents.
Chen Y; Liu HR; Liu HS; Cheng M; Xia P; Qian K; Wu PC; Lai CY; Xia Y; Yang ZY; Morris-Natschke SL; Lee KH
Eur J Med Chem; 2012 Mar; 49():74-85. PubMed ID: 22265685
[TBL] [Abstract][Full Text] [Related]
11. DC120, a novel and potent inhibitor of AKT kinase, induces tumor cell apoptosis and suppresses tumor growth.
Deng R; Yang F; Chang SH; Tang J; Qin J; Feng GK; Ding K; Zhu XF
Mol Pharmacol; 2012 Aug; 82(2):189-98. PubMed ID: 22553359
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-alpha in head and neck cancer cells in vitro and in vivo.
Bruzzese F; Di Gennaro E; Avallone A; Pepe S; Arra C; Caraglia M; Tagliaferri P; Budillon A
Clin Cancer Res; 2006 Jan; 12(2):617-25. PubMed ID: 16428508
[TBL] [Abstract][Full Text] [Related]
13. Rhein lysinate suppresses the growth of breast cancer cells and potentiates the inhibitory effect of Taxol in athymic mice.
Lin YJ; Zhen YS
Anticancer Drugs; 2009 Jan; 20(1):65-72. PubMed ID: 19343002
[TBL] [Abstract][Full Text] [Related]
14. Novel Nitric Oxide Donors of Phenylsulfonylfuroxan and 3-Benzyl Coumarin Derivatives as Potent Antitumor Agents.
Guo Y; Wang Y; Li H; Wang K; Wan Q; Li J; Zhou Y; Chen Y
ACS Med Chem Lett; 2018 May; 9(5):502-506. PubMed ID: 29795767
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activities of JTP-74057 (GSK1120212), a novel MEK1/2 inhibitor, on colorectal cancer cell lines in vitro and in vivo.
Yamaguchi T; Kakefuda R; Tajima N; Sowa Y; Sakai T
Int J Oncol; 2011 Jul; 39(1):23-31. PubMed ID: 21523318
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents.
Zhang W; Li Z; Zhou M; Wu F; Hou X; Luo H; Liu H; Han X; Yan G; Ding Z; Li R
Bioorg Med Chem Lett; 2014 Feb; 24(3):799-807. PubMed ID: 24418772
[TBL] [Abstract][Full Text] [Related]
17. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
[TBL] [Abstract][Full Text] [Related]
18. Isoobtusilactone A induces cell cycle arrest and apoptosis through reactive oxygen species/apoptosis signal-regulating kinase 1 signaling pathway in human breast cancer cells.
Kuo PL; Chen CY; Hsu YL
Cancer Res; 2007 Aug; 67(15):7406-20. PubMed ID: 17671211
[TBL] [Abstract][Full Text] [Related]
19. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.
Manetta A; Gamboa G; Nasseri A; Podnos YD; Emma D; Dorion G; Rawlings L; Carpenter PM; Bustamante A; Patel J; Rideout D
Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539
[TBL] [Abstract][Full Text] [Related]
20. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
